8-methyl-4-[2-(trifluoromethyl)benzoyl]-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Cäsiumacetat 99,99 % 25 g

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, 98%, 25g

ROTI®Elutionsgefäße MIDI 1, 50-800 µl, 1 Stück

C-[1-(3-Bromo-benzenesulfonyl)-piperidin-4-yl]-methylamine hydrochloride, 95.0%, 250mg

(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid, 95%, 5g

1-(3,4-Difluorophenyl)cyclopropane-1-carboxylic acid, 97%, 1g

Ethyl 1-isopropyl-4-nitro-1h-pyrazole-3-carboxylate, 97%, 1g

5-Chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 5g

2-Chloro-4,6-diphenyl-1,3,5-triazine, 95.0%, 25g

Ethyl 4H-Thieno[3,2-b]pyrrole-5-carboxylate, 97.0%, 25g

6-Hydroxy-2,4,5-triaminopyrimidine, 97.0%, 25g

Methyl 3-bromo-4-chlorobenzoate, 95.0%, 1g